Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.8B | 4.9B | 4.7B | 5.5B |
| Cost of revenue | 2.6B | 3.3B | 3.1B | 3.7B |
| Gross profit | 1.3B | 1.6B | 1.5B | 1.8B |
| Operating expense | ||||
| Research & development | 184M | 238M | 221M | 237M |
| Selling general and admin | 386M | 414M | 426M | 461M |
| Other operating expenses | — | — | — | — |
| Operating income | 689M | 901M | 877M | 1.1B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 362M | 421M | 378M | 418M |
| Other income expense | -165M | -239M | -139M | -216M |
| Pretax income | 162M | 241M | 360M | 454M |
| Tax provision | 47M | 89M | 75M | 95M |
| Net income | 132M | 176M | 310M | 438M |
| Basic EPS | 0.1 | 0.1 | 0.2 | 0.3 |
| Diluted EPS | 0.1 | 0.1 | 0.2 | 0.3 |
| Basic average shares | 1.2B | 1.2B | 1.3B | 1.3B |
| Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
| EBITDA | 680M | 837M | 905M | 1.1B |
| Net income from continuing op. | 132M | 176M | 243M | 471M |
| Minority interests | -1M | -3M | -4M | -5M |
| Preferred stock dividends | — | — | — | — |